PART II: Implications of plasmid DNA fragments in blood products
Blind spots in the oversight of blood products, leaves the public in a dangerous state of speculation.
@Kevin_McKernan @Jikkyleaksblog.maryannedemasi.com/p/part-ii-impl…
Blind spots in the oversight of blood products, leaves the public in a dangerous state of speculation.
@Kevin_McKernan @Jikkyleaksblog.maryannedemasi.com/p/part-ii-impl…
Gene fragments encoding 'SV40' and 'Kanamycin,' which are specific to the plasmid DNA used in vaccine manufacturing of mRNA vaccines, have been identified in blood samples.
If these genetic sequences can persist in the bloodstream after vaccination, and potentially end up in blood products such as fresh frozen plasma, whole blood, or cryoprecipitate, what risks might they pose to recipients?"
If these genetic sequences can persist in the bloodstream after vaccination, and potentially end up in blood products such as fresh frozen plasma, whole blood, or cryoprecipitate, what risks might they pose to recipients?"
Australian Red Cross says there is no evidence risk to a recipient. But it does not track the COVID-19 vaccination status of donors, nor has it tested for these genetic components of mRNA vaccines in donated blood. @RedCrossAU
Dr Richard Davis, former member of the SA Red Cross blood transfusion committee, has questioned the robustness of these assurances.
“If the Red Cross is not documenting the vaccination status of donors, how can it possibly track any harm?”
“Further, the Red Cross should not claim there is no evidence of risk to recipients when such effects may take years to manifest,” he added.
“If the Red Cross is not documenting the vaccination status of donors, how can it possibly track any harm?”
“Further, the Red Cross should not claim there is no evidence of risk to recipients when such effects may take years to manifest,” he added.
As late as September 2022, American @RedCross stated on X, “the COVID-19 vaccine does not enter the bloodstream.”
But findings by Chakraborty, data from biodistribution studies in Japanese regulatory documents, and a study published this month in Nature, all clearly show that the vaccine leaves the injection site and circulates widely throughout the body.
But findings by Chakraborty, data from biodistribution studies in Japanese regulatory documents, and a study published this month in Nature, all clearly show that the vaccine leaves the injection site and circulates widely throughout the body.
“Without data, we are left in a dangerous state of speculation,” Dr Davis said.
For the full story 👇👇 blog.maryannedemasi.com/p/part-ii-impl…
For the full story 👇👇 blog.maryannedemasi.com/p/part-ii-impl…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
